Cargando…
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of liver damage from the more prevalent (75%–80%) and nonprogressive nonalcoholic fatty liver (NAFL) category to its less common and more ominous subset, nonalcoholic steatohepatitis (NASH). NAFLD is now the most common cause of ch...
Autores principales: | Iqbal, Umair, Perumpail, Brandon J., Akhtar, Daud, Kim, Donghee, Ahmed, Aijaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473603/ https://www.ncbi.nlm.nih.gov/pubmed/30889791 http://dx.doi.org/10.3390/medicines6010041 |
Ejemplares similares
-
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
por: Perumpail, Brandon J, et al.
Publicado: (2017) -
Recent Epidemiology of Nonalcoholic Fatty Liver Disease
por: Murag, Soumya, et al.
Publicado: (2021) -
Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
por: Akhtar, Daud H., et al.
Publicado: (2019) -
Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
por: Konyn, Peter, et al.
Publicado: (2023) -
Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease
por: Dibba, Pratima, et al.
Publicado: (2018)